PKI 14-22 amide, myristoylated Acetate inhibit cAMP-dependent protein kinase (PKA) and blocks hyperalgesia produced by spinal administration of 8-bromo-cAMP.
Molecular Weight:
1269.54
Purity:
96.34%
Formula:
C55H104N20O14
Target:
PKA
T21983L
* VAT and and shipping costs not included. Errors and price changes excepted